At baseline, there were no differences between these groups in age, sex, ethnicity, duration of diabetes, metformin monotherapy before the trial, BMI, waist or insulin sensitivity/resistance (Matsuda index, Homeostasis Model of Assessment of Insulin Resistance (HOMA-IR)). The gene discussed is INS; the disease is diabetes mellitus.